Second Sight Medical Products soars 592% after the FDA approves its visual prosthetic system

Spencer Platt/Getty Images
Second Sight Medical shares jumped to nearly $10 after the FDA approved its Argus2 Retinal Prosthesis System. 
The regulatory approval arrives as Second Sight works to complete a business combination with France's Pixium Vision. 
A decision on when or if to begin production of the new hardware is pending the completion of the deal with Pixium. 
Visit the Business section of Insider for more stories.
Shares of Second Sight Medical Products shot up by near